Genomic Valley Biotech P/B Ratio

Current P/B Ratio
2.26
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model

Genomic Valley Biotech P/B ratio. Genomic Valley Biotech (GVBL) P/B ratio is 2.26 (Moderate), book value per share ₹13.33 vs Healthcare average P/B of 0.01 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see Genomic Valley Biotech stock price NSE.

Current Valuation Metrics

P/B Ratio 2.26
Current Price ₹29.25
Book Value/Share ₹13.33
Exchange BSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹4 Cr
Share Capital ₹3 Cr
Reserves & Surplus ₹1 Cr
Outstanding Shares 3,000,000
Book Value per Share ₹13.33

Valuation Signal

Signal Fairly Valued
Historical Avg 3.05
Historical Range 1.85 - 6.0
Percentile 40.0%

Sector Context

Sector Average 0.01
Sector Median 0.65
Sector Rank #11 of 50
Sector Percentile 22.0%

GVBL P/B Ratio — Valuation Insights & Book Value Analysis

Genomic Valley Biotech price-to-book ratio interpretation, valuation status and historical context — current P/B 2.26 (Moderate). View Genomic Valley Biotech yearly highs lows for the annual high/low range and current price position.

  • Current PB is 26.0% below historical average
  • Trading at premium to sector average PB of 0.01

Genomic Valley Biotech P/B Ratio Historical Trend

GVBL annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse GVBL shareholder distribution to track promoter, FII and institutional holdings.

GVBL Historical P/B Ratio — Book Value Per Share & Year-End Price

Genomic Valley Biotech annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 2.19 ₹13.33 ₹29.25 ₹4 Moderate
2025 1.85 ₹13.33 ₹24.71 ₹4 Moderate
2024 6.0 ₹13.33 ₹79.95 ₹4 High
2023 2.81 ₹13.33 ₹37.44 ₹4 Moderate
2022 2.41 ₹10.0 ₹24.05 ₹3 Moderate

GVBL vs Healthcare Peers — P/B Ratio Comparison

Genomic Valley Biotech P/B 2.26 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.

Sector Average
0.01
Sector Median
0.65
Lowest P/B
-6.55
Highest P/B
1.13
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹35 Low
Krebs Biochemicals & Ind… KREBSBIO -0.8 ₹147 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹47 Low
Triochem Products TRIPR 0.04 ₹0 Low